Peter Blissett’s Post

🎄 𝑫𝒂𝒚 2: 𝑪𝒐𝒏𝒕𝒊𝒏𝒖𝒖𝒔 𝑷𝒉𝒂𝒓𝒎𝒂𝒄𝒆𝒖𝒕𝒊𝒄𝒂𝒍𝒔 🎄 This US small molecule company, CONTINUUS Pharmaceuticals, have gained attention in the manufacturing space due to their innovation in end-to-end continuous technology. Some highlights!! ✨ The fourth annual Commercializing Flow Chemistry Summit partnered with Stephen Born, Co-Founder and Scientific Director to share insights into how CONTINUUS Pharmaceuticals are directly developing solutions to combat prevalent issues in flow chemistry manufacturing ✨ Published a case study paper on their innovative ICM Pilot Plant which uses a process to take molecules from raw material dissolution, through reactive crystallization, to drug product formulation ✨ Designed a process that reduces waste generation by 30%, and will save approx. $1.5m per 1000 tons of API manufactured ✨ Reduced CO2 emissions through new processes by 120 tons per 1000 tons of product Amazing to see new businesses making a difference in new tech as well developing ways to make pharma manufacturing better for the environment!! #continuuspharma #continuousmanufacturing #cdmo #cmo #pharma #pharmaceuticals #letspivot